CN Stock MarketDetailed Quotes

600276 Jiangsu Hengrui Pharmaceuticals

Watchlist
  • 50.19
  • -0.27-0.54%
Not Open Nov 21 15:00 CST
320.16BMarket Cap58.77P/E (TTM)

Jiangsu Hengrui Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Jiangsu Hengrui Pharmaceuticals Q3 2024 Earnings Date

Currency：CNYOct 25, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
6.73B
6.59B
-145.67M
Miss Est.
+15.21%
+12.72%
-2.16%
EPS
0.23
0.19
-0.04
Miss Est.
+19.05%
--
-16.00%
Analyst Rating
Strong Buy

Nov 21, 2024

Jiangsu Hengrui Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 6.572B--
--2024/Q4-- / 7.088B--
Oct 25, 20242024/Q36.589B / 6.734B--
Aug 22, 20242024/Q27.603B / 6.648B--
Apr 18, 20242024/Q15.998B / 6.071B--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 6.572B--
--2024/Q4-- / 7.088B--
Oct 25, 20242024/Q36.589B / 6.734B--
Aug 22, 20242024/Q27.603B / 6.648B--
Apr 18, 20242024/Q15.998B / 6.071B--

Unlock Free Earnings Estimates

Jiangsu Hengrui Pharmaceuticals Earnings Reports

  • Hengrui Pharmaceutical Report for the Third Quarter of 2024

    Oct 25 00:00

  • Jiangsu Hengrui Pharmaceuticals 2024 Semi-Annual Report

    Aug 22 00:00

  • Summary of Jiangsu Hengrui Pharmaceuticals' 2024 interim report

    Aug 22 00:00

  • Summary of Hengrui Pharmaceutical\'s 2023 Annual Report

    Apr 18 00:00

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 21, 2024

    Strong Buy

    • Strong Buy

      89.47%

    • Buy

      7.90%

    • Hold

      2.63%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    % Chg

    No Data